Alma Accent Prime Slimming
Alma Accent Prime Slimming is an advanced non-invasive treatment that aims to reduce localized body fat and improve body contours. This innovative treatment utilizes a combination of Ultrasound (US) and Radiofrequency (RF) technologies to target specific areas of the body and stimulate fat reduction. Alma Accent Prime Slimming aims to provide individuals with a non-surgical alternative to traditional liposuction procedures.
The technology used in Alma Accent Prime Slimming is based on two fundamental principles: ultrasound cavitation and radiofrequency energy.
Questions
We got the answers.
- Ultrasound cavitation uses high-frequency sound waves that penetrate the skin and disrupt fat cells. This process causes the fat cells to release their contents, which are then naturally eliminated by the body’s lymphatic system.
- Radiofrequency energy stimulates collagen production and tightens the skin.
Radiofrequency waves penetrate the deeper layers of the skin, causing a thermal effect that triggers collagen remodeling. As a result, skin improves elasticity and gets a more toned appearance.
The results may be noticeable after just one treatment and will continue to improve for several weeks following the last treatment session. The body will continue to metabolize fat for up to 12 weeks. This procedure will also make your skin firmer and smoother looking.
- Arms
- Buttocks
- Abdomen
- Legs
- Face
Alma for face can be done once every 10 days, with a course of 3-6 sessions.
Alma for body can be done once every 10 days, with a course of 3-10 sessions.
Alma for face slimming can be combined with other treatments, such as the meso v-shape, signature face massage, and microcurrents.
Alma for body contouring can be combined with meso fat-dissolving injections, pressotherapy, transion, anti-cellulite massage, vacuum roller, and endosphere.
There is no downtime, which means that following the treatment, you can resume your daily activities without discomfort or side effects.
The treatment with radio waves and ultrasound should not be performed in pregnant women, patients with cancer, chronic liver and kidney diseases, diabetes, epilepsy, venous thrombosis, or heart disease.
